Global Water Softening Systems Market Forecast with Potential Impact, Despite COVID-19 Pandemic, Finds FMI 2021 – 2031

As per ESOMAR-certified consulting firm Future Market Insights (FMI) recent market survey, the global water softening systems market is anticipated to expand at a robust 6.5% CAGR between 2021 and 2031, surpassing a market valuation of US$ 10.82 Bn in 2021.

Water softening systems demand outlook remains positive, with the market size projected to expand at a robust 6.5% CAGR over the assessment period. Awareness regarding water quality and policies favoring implementation of advanced technologies will create a conducive environment for growth.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-881

Key Points Covered in Water Softening Systems Market Survey
  • Market estimates and forecast 2021-2031
  • Key drivers and restraints impacting market growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Brand share and Market Share Analysis
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact on Water Softening Systems Market and how to Navigate
  • Recommendation on Key Winning Strategies

Key trends shaping the water softening systems market include product innovations in the systems associated with high efficacy, technological advancements, and durability, along with growing concerns regarding water contamination across the globe.

Increasing adoption of water softening systems due to excessive mineral composition in water will drive sales in developed countries such as the U.S., the U.K., Germany, and Italy. The presence of leading market players will also augment market growth during the forecast period.

Growing awareness regarding water quality and government-led initiatives such as smart cities, coupled with non-governmental initiatives for promoting water sanitation and public health will generate demand in emerging markets including India, China, South Korea, and Brazil.

Application will continue increasing in the residential sector. FMI sees impressive prospects for non-electric water softening systems sales across households. Government policies adopted towards making clean water available for all will continue aiding sales growth in this segment.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-1085

Competitive Landscape

EcoWater Systems LLC, Culligan International Company, Kinetico Incorporated, Hydroflux, Envicare Technologies Pvt. Ltd., Wychwood Water Systems Ltd., Harvey Water Softeners Ltd., Pelican Water Systems, BWT AG, Marlo Incorporated, Monarch Water Ltd., Qingdao Haier Co., Ltd., Atlas Filtri, Watts Water Technologies Inc., Feedwater Limited and Canature Health Technology Group Co Ltd. are among the top manufactures in water softening systems market, as profiled by FMI.

Water Softening Systems Market Historic Sales Compared to 2021-2031 Forecast Outlook

As per FMI’s analysis, demand for ultra-soft water softening systems visibly grew due to soaring concerns pertaining to water contamination across the globe. However, amid the COVID-19 outbreak, sales reduced to an extent, especially on account of restrictions imposed on movement, which halted product installation in various residential, commercial, and industrial spaces.

However, growth is on the cards, with sales of salt-free water softening systems and increasing shift towards electrification and automation of industrial filtration systems and water treatment equipment, emerging as key trends in the market.

Government initiatives in collaboration with water supply management authorities that are aimed to establish a reliable supply chain will foster sales in the market. FMI forecasts water softening systems sales to grow by 6.5% CAGR between 2021 and 2031, as against growth at 4.7% registered between 2016 and 2020.

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-1085

Water Softening Systems Market by Category

By Operation Type: 

  • Electric
  • Non-Electric

By Application Type:

  • Residential
    • Salt-based
    • Salt-free
  • Industrial
  • Commercial

By Design:

  • Mono Cylinder
  • Twin Cylinder
  • Multi-Cylinder

By Region: 

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • Asia Pacific excluding Japan
  • Japan
  • Middle East and Africa (MEA)

Pulmonology Devices Market to grow at 10.7% CAGR through 2020 to 2030 – FMI

Respiratory disorders such as asthma, chronic obstructive pulmonary disorder (COPD), and lung cancer is on the rise globally. Smoking and unhealthy living environment are often identified as common causes fuelling the incidence of respiratory disorders. According to Future Market Insights (FMI), driven by the rising incidence of respiratory diseases the demand for pulmonology devices will rise. The market is therefore expected to surpass US$ 1.08 Bn by 2021.

Government initiatives supported by public and private organizations to spread awareness has led people to focus on early diagnosis of medical conditions to avoid delay in treatment. Furthermore, a number of players are developing new products to expand their product portfolio as well as to maintain their position in the market.

Request a report sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-13036

In its new study, FMI offers insights about key factors driving demand for pulmonology devices. The study points toward single-use bronchoscopes being the most sought-after due to the Increasing adaption of single-use bronchoscopes in lung cancer. COPD by indication hold more than thirty percent market share, globally. The report also tracks global sales of pulmonology devices in 20+ high-growth markets, along with analyzing the impact COVID-19 has on the medical device industry in general, and pulmonology devices in particular.

For an instance Olympus has launched a few unique pulmonology devices such as the flexible bronchoscope that has helped the company in maintaining its position in the market. A large number of domestic players are slowly emerging in Asia Pacific. Rise in healthcare expenditure in developing countries and improving reimbursement policies are causing shift in focus among market players from developed to developing countries.

Moreover, the availability of pulmonology devices for healthcare professionals has been impacted by COVID-19 supply chain crisis. However, there are measures taken to manage this situation. Governments have relaxed controls to make supply easy. Export controls have been made easy by several manufacturing countries.

Major manufacturers in the pulmonology devices market are geared up and focusing on local production of pulmonology devices. According to the report, the increasing cases COPD and lung cancer will continue fuelling demand in the market.

Discover more about report analysis with figures and data tables, along with the table of contents. Ask an Analyst- https://www.futuremarketinsights.com/ask-question/rep-gb-13036

Key Takeaways from pulmonology devices Marker Study

  • The demand for pulmonology devices is expected to get higher, enabling the market to exhibit 10.8% CAGR between 2020 and 2030
  • Backed by increasing healthcare spending, the U.S. is expected to account for nearly 90% sales in North America
  • Favorable reimbursement policies will enable the U.K. to exhibit 13% y-o-y growth in 2021
  • Germany and France will showcase increasing investment towards expanding healthcare infrastructure, in turn fuelling the demand for pulmonology devices
  • Within East Asia, Japan and South Korea will represent highly attractive markets for sale

 “Some of the emerging regions such as South Asia have been adopting minimally invasive surgeries to accelerate rate of diagnosis and treatment of lung cancer. The rising demand for pulmonology devices and increasing focus on development of advance devices will remain chief drivers of the market.” says the FMI Analyst

Contact Sales for Further Assistance in Purchasing this Report- https://www.futuremarketinsights.com/checkout/13036

Competitive Landscape

Leading players in the pulmonology devices market on strengthening their market position though the Acquisition, Partnerships and expansion. For Instance,

  • In February 2019, the Conmed Corporation acquired privately-held Buffalo Filter LLC, a leader in surgical smoke evacuation technologies. The company’s comprehensive product portfolio includes smoke evacuation pencils, smoke evacuators, and laparoscopic solutions.
  • In November 2019, Cook Medical opened new facility in India. This office enables the company to expand its business in emerging markets.
  • In January 2019, the Verathon, Inc launched GlideScope® BFlex™, a single-use flexible bronchoscope that offers optimal visibility and maneuverability for routine airway and bronchoscopy procedures.

The key market players covered by FMI include Boston Scientific Corporation, CONMED Corporation, Olympus Corporation, Cook Medical Incorporated, Medi-Globe GmbH, Ambu A/S, Verathon, Inc, consolidating their positions through mergers, acquisitions and new product launches.

World Ultra Violet (UV) Lamps Market Size, Share, Outlook, Overview, Region, Application And Forecast 2021-2031

The global UV lamps market is anticipated to register a double-digit CAGR during the forecast period. Growth of the global UV lamps market is mainly driven by increasing industrial development and stringent government regulations. Moreover, trends in the global UV lamps market include increasing adoption of UV systems in the healthcare sector and the food and beverages industries.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-1065

UV lamps are basic lamps that emit ultraviolet radiation with a wavelength ranging between 400 nm and 100nm. UV light is basically classified into three wavelengths: UV-A, UV-B and UV-C. This report covers UV-C, also known as germicidal UV – with wave length ranging between 100 nm to 280 nm – and its purpose is to disinfect or deactivate the DNA and RNA of bacteria, viruses and other pathogens, thus inhibiting their ability to multiply.

Future Market Insights (FMI) delivers key insights on the global UV lamps market in its latest report. Global UV lamps market revenue is projected to expand at a CAGR of 11.3% during the forecast period due to various factors, regarding which FMI offers vital insights in detail in its report.

On the basis of lamp type, the market has been segmented into UV LED and UV mercury lamp, with the latter representing nearly 90% revenue share of the global UV lamp market in 2014; FMI expects this segment to witness a decline of 27 BPS by the end of 2025.

UV mercury lamp segment is categorised into low-pressure, medium- pressure and amalgam mercury lamp. Among these, amalgam mercury lamp dominated the UV mercury lamp segment market, accounting for over 40% of the UV mercury lamp market in 2014.

On the basis of end-use application, the UV lamps market is segmented into wastewater treatment, water treatment, air treatment, surface treatment and food and beverages disinfection. Revenue contribution by the food and beverages disinfection segment was over 25.1% in 2014, which is projected to increase to 28.2% by the end of 2025, gaining 309 BPS and expanding at a CAGR of 12.5% during the forecast period.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-1065

Water treatment segment is categorised into industrial process water treatment, water treatment, commercial water treatment, residential water treatment, municipal pool and spa, and others. Municipal water treatment sub-segment accounted for the highest revenues in 2014, and this trend is expected to continue through 2025.

Air treatment is further sub-segmented into residential and commercial, healthcare facilities, and others. Among these, residential and commercial sub-segments accounted for bulk of the revenues in 2014; FMI estimates this segment to retain its dominance throughout the forecast period.

Key Regions

The global UV lamps market has been sub-segmented into seven major regions which include North America, Western Europe, Asia Pacific Excluding Japan (APEJ), Japan, Eastern Europe, Latin America and Middle East & Africa. APEJ dominated the market with over 30% of the overall UV lamp market share in 2014, while Eastern Europe followed with over 20% market share. In addition, APEJ is anticipated to be the fastest growing region in the UV lamp market in terms of revenue contribution.

Key Players

Some key players identified in global UV lamp market are Xylem Inc., Calgon Carbon Corporation, Trojan Technologies Inc., Koninklijke Philips N.V., Halma PLC, Heraeus Holding Gmbh, Severn Trent PLC, Xenex Disinfection Services LLC, OSRAM GmbH and Atlantic Ultraviolet Corporation.

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-1065

Key Segments Covered

  • UV Lamps Market
    • Lamp Type
      • UV Mercury Lamp
        • Low-pressure Mercury Lamp
        • Medium-pressure Mercury Lamp
        • Amalgam Mercury Lamp
      • UV LED
    • End-use Application
      • Wastewater Treatment
      • Water Treatment
        • Municipal Water Treatment
        • Residential Water Treatment
        • Industrial Process Water Treatment
        • Commercial Water Treatment
        • Pool and spa
        • Others
      • Air treatment
        • Healthcare Facilities
        • Residential and Commercial
        • Others
      • Surface Treatment
      • Food and Beverages
        • Bottled Water and Other Beverages
        • Marinades and Brines
        • Surface Disinfection of Food

Dose Monitoring Devices Market 2021 Key Players – GE healthcare (U.K), Siemens Healthcare (Germany), Sectra Medical systems (Sweden), Philips N.V (Netherlands), Bayer AG (Germany)

Dose monitoring devices are devices which provides immediate enterprise-wide visibility into patient dose exposure for multiple modalities and PACS (Picture Archiving and Communication System). Dose monitoring devices are suitable for any size of healthcare facility, these devices provides patient radiation dose insights, monitoring and reporting with minimal staff involvement at a reasonable cost.

Dose monitoring devices provides the greatest access and flexibility in how you monitor, use and export dose data regardless of a hospitals size or configuration or number of modalities, units or even PACS system.

These devices enable the administration of reliable, automated radiation dose information and provide tools that support patient safety management and regulatory reporting requirements while improving quality assurance. These devices enables radiation dose tracking, dose analytics capabilities, dose reduction, and help in processing of better quality images.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-736

Dose Monitoring Devices Market: Drivers and Restraints:

Presently, dose monitoring devices market is drive is by the technological advancement, increasing need for patient safety, compliance obligations of healthcare providers with stringent state and federal laws.

Dose monitoring device global market is driven by the technological advancement, rapid innovation in production and modeling technologies, increasing computed tomography procedures performed around the globe, increase in adoption of electronic health records (EHRs), and increasing awareness and knowledge among patients regarding the consequences of prolonged or extended radiation exposure. However, lack of funding, ignorance towards radiation dose management by healthcare professionals, and lack of set skilled professionals act as major barrier for this market around the globe.

Dose Monitoring Devices Market: Overview:

With rapid technological advancement,increasing need for patient safety and increasing awareness and knowledge among patients regarding the consequences of prolonged or extended radiation exposure the dose monitoring devices global market is expected to have a healthy growth rate in the forecast period (2015-2025).

Dose Monitoring Devices Market: Region-wise Outlook:

Depending on geographic regions, global dose monitoring devices market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

Geographically, North America dominates the market primarily due to strict regulations for patient safety and patient care. Factors like increasing risks and incidences of chronic disorders and increasing measures for patient safety are driving the growth of this market in this region.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-736

Dose Monitoring Devices Market: Key players:

Some of the key participating global players of this market are GE healthcare (U.K), Siemens Healthcare (Germany), Sectra Medical systems (Sweden), Philips N.V (Netherlands), Bayer AG (Germany) and others, IBA Dosimetry GmbH and Mirion Technologies, Inc.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

Market Segments

Market Dynamics

Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies involved

Technology

Value Chain

Regional analysis includes:

North America (U.S., Canada)

Latin America (Mexico. Brazil)

Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)

Eastern Europe (Poland, Russia)

Asia Pacific (China, India, Australia & New Zealand)

Japan

Middle East and Africa (S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Dose Monitoring Devices Market: Segmentation:

Dose monitoring devices market is segmented into following types:

On the basis of product:

Medical Radiation Dosimeters

Radiation Survey Meters

Dose Monitoring Software

Service

On the basis of application:

Radiography

Computed Radiography

Mammography

Fluoroscopy and Interventional Imaging

Others (Nuclear Medicine)

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-736

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Must-have information for market players to sustain and enhance their market footprint

Below 30 Hp Centrifugal Water Pump Market Competitive Growth Strategies Based on Type, Applications, End User and Region

Centrifugal water pumps account for more than 50% share of the overall pumps market and are widely used in number of small and large scale industrial applications, such as power, waste water treatment and chemicals. The use of centrifugal water pumps for domestic and agriculture purposes makes them even more attractive. In addition, need for new water sources is expected to lead to a rise in the sales of centrifugal water pumps that carry enhanced capacity and efficiency needed for agriculture and domestic applications.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-704 

Increasing cost of energy and growing environmental awareness among end-users are likely to drive the demand for cost-effective and energy-efficient centrifugal water pumps over the forecast period. In this report, the below 30 Hp centrifugal water pump market in Egypt is segmented on the basis of pump type, end-user application and capacity.Pumps within a capacity range of 0.5 to 30 HP are considered in this study. By pump type, the market is segmented into monobloc pumps, mini-pumps and submersible pumps. Meanwhile, by end-user application, the market is segmented into industrial, agriculture and domestic applications.

The below 30 Hp centrifugal water pump market is projected to expand at a CAGR of 5.3% in terms of revenue, in order to reach US$ 37.1 million by the end of 2020. In terms of volume, the below 30 Hp centrifugal water pump market in Egypt is expected to rise from 55,537 units to 72,530 units by the end of 2020.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-704

Segmentation, by ApplicationThe below 30 Hp centrifugal water pump market in Egypt is segmented into three major applications, namely industrial, agriculture and domestic. The domestic application segment currently accounts for more than 40% share of the overall below 30 Hp centrifugal water pumps market in Egypt in terms of revenue, and is estimated to expand at a steady CAGR during the forecast period.

Meanwhile, among the three applications, the industrial application segment is expected to expand at the highest CAGR of 5.5% in terms of revenue.

Segmentation, by CapacityThe below 30 Hp centrifugal water pumps market in Egypt has been segmented in terms of capacity, from 0.5 HP (minimum) to 30 HP (maximum), for all the three types of the mentioned pump types. Among all the product capacities, the 25-30 HP pumps are most widely preferred.

As far as the monobloc and submersible pumps are concerned, the 25-30 HP pumps find wider applications, whereas the 1-2 HP pumps account for more than 50% share of the overall mini pumps segment.

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-704

Key PlayersMajor players in the below 30 Hp centrifugal water pump market in Egypt include Grundfos,  KSB Pumps Ltd., Xylem Inc., Wilo SE, Flowserve Corporation, Calpeda S.p.A, and Omega Egypt Co. The centrifugal water pump industry in Egypt is largely consolidated, as the regional and local players hold a collective revenue share of 70% of the total centrifugal water pump market in the country. Grundfos accounts for largest share in the centrifugal water pump market, followed by KSB Pumps Egypt and Wilo SE.

Virtual Companion Care Market Size Estimation By Share 2021: Business Opportunities, Industry Growth, Sales Revenue And Industry Expansion Strategies 2027

In the age of digitization, relationship between patients and care-givers or health maintenance organizations is changing rapidly as various technologies are being employed by primary and secondary users of health care services across the globe. The popularity of virtual worlds is increasing over the time and healthcare systems are thus using it for promoting healthy behavior. Virtual companion care represents an example of virtual reality that represents a virtual agent which is incorporated with an artificial conversational entity like cathbot, and can display appropriate non-verbal behavior after communicating with existing healthcare databases. Elder population can talk to them in a normal conversational tone and the virtual agent can speak back, answer questions, read news for them, etc. Many elderly people living alone at home require companionship. There are different technologies such as mobile phones and computers that can connect these elderly patients to their families however these technologies can provide only companionship as much as busy family members can do. Virtual companion care provides alternative that can be a substitute for in-person human contact and alleviate loneliness. The concept of virtual caregiving however cannot replace the human companionship although it can be viewed as a way to decrease the time for companion sessions and thus is cost saving. The cost of virtual companion care services in the U.S. is approximately US$ 200 per month. Virtual companion care services have made caring for seniors very easy and feasible.

Virtual Companion Care Market: Drivers and Restraints

Primary factors driving growth of virtual companion care market are rapidly growing geriatric population, technological advancements, penetration of technology among general population and elderly population and need for companion care services due to elder population living alone at the home. According to U.S. Department of Health and Human Services and the National Ambulatory Medical Care survey, population aged over 65 in the U.S. will be doubled by 2030. Majority of elderly people may not need assistance but require companionship and thus virtual companion care is adopted by them. Even though information society is gaining importance over time elderly people are major challenge in this respect as they lack interest and knowledge of technological progress. This is expected to limit the growth of virtual companion care market.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5526

Virtual Companion Care Market: Overview

Market for virtual companion care is in early stage of development and majority of population in developing countries is yet to know about it. Majority of the platforms are being developed by the universities and are expected to be completed and launched over the forecast period of 2017–2027. Even in developed countries such as the U.S. and European countries the concept of virtual companionship is not readily adopted by the general population. Under its Eurostatrs Program, European Union is developing Naviga platform which allows elder people and persons with disability to access the internet and the information society. The platform also provides home rehabilitation physiotherapy through virtual reality applications.

Virtual Companion Care Market: Regional Outlook

Geographically, global virtual companion care market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America clearly dominates the global virtual companion care market due to high penetration of technology and internet among elderly population. Europe is expected to be the second largest market due to government initiatives for providing companion care to elderly. Japan virtual companion care market is expected to witness robust growth due to number of companies working to develop virtual platforms for elderly care.

Virtual Companion Care Market: Key Players

Some of the players identified in global virtual companion care market include Claris Healthcare Inc., General Electric Company, AIST Japan, GeriJoy Limited, Living Assistance Services Inc. etc.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

Market Segments

Market Dynamics

Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies involved

Technology

Value Chain

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-5526

Regional analysis includes:

North America (U.S., Canada)

Latin America (Mexico. Brazil)

Western Europe (Germany, Italy, France, U.K, Spain)

Eastern Europe (Poland, Russia)

Asia Pacific (China, India, ASEAN, Australia & New Zealand)

Japan

Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Virtual Companion Care Market: Segmentation

Tentatively, global virtual companion care market has been segmented on the basis of end user, and geography

Based on end user, global virtual companion care market is segmented as below:

Long-term Care Centers

Home Care Settings

Rehabilitation Centers

Old Age Homes

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-5526

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Neurovascular Access Catheters Market Outlook, Current and Future Industry Landscape Analysis Forecast To 2021 – 2025

Immunochemistry analyzer are becoming more and more popular in the global clinical chemistry and immunoassay as these are proved to be very effective tool to diagnose cancer, hepatitis, illegal drugs, fertility problems, sodium levels, endocrine function, and the detection of blood clots.

There are approximately more than 180,000 immunochemistry analyzers were installed globally in 2013. Out of which only about 17-20% of these analyzers are installed in the United States. This statistic suggests that the markets like China, India, and Japan where there is lack of basic lab facility prevails are adopting this new technology .Also it’s been seen that the recurring consumable sales are a strong factor to segment growth.

Immunochemistry analyzers are instruments that automatically run tests on samples from patients to detect any number of biologically active substances .It is very important to know which analyzer to use as different analyzers have different analysis time, and need different reagents which make these instrument highly sophisticated. These analyzers are mainly being used in infectious disease testing, cancer, cardiac, and autoimmune diseases.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-9189

Immunochemistry Analyzer Market: Drivers and Restraints

Under the strong rules & regulation laboratories find it difficult to have good revenues. Thus it’s very important to find ways to sustain in such a cost-crunched environment. Due to the cost cutting in clinical lab fees, profitability per test is decreasing which makes it necessary for the laboratories to focus on the volume rather than the value. There is also heavy pressure for quality, error-free results to ensure patient satisfaction. This forces labs to lean toward more automated systems with effective workflow solutions.

In US, Laboratories are encouraged for automation due to the heavy influx of patients with insurance coverage. But with limited workforce in the clinical lab it’s difficult to manage the huge inflow of patients. On the other hand patients need prompt & error free results. Thus this scenario demands laboratories to seek the help of systems that have a high accuracy, with managing high growing volumes and also offer remote data acquisition capabilities. The automated analyzers working with barcode readers, rack detection systems, and sample/plate identification modules to avoid plate or sample switch.

Immunochemistry Analyzer Market : Overview

With the rapid technological advancement in healthcare industry the immunochemistry analyzer market is expected to grow at a healthy CAGR in the forecasted period (2015-2025).

Globally, the immunochemistry market represents approximately 40.1% of the global in vitro diagnostics (IVD) market. Immunochemistry is by far the largest segment by volume, mostly due to routine testing. It is primarily driven by growing access to healthcare.

Immunochemistry Analyzer Market : Region-wise Outlook

Depending on geographic region, global immunochemistry analyzer market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

Demand for immunochemistry analyzers is slowing in the US and Western and Eastern Europe. Europe’s challenges in this segment include laboratory consolidation in France and economically troubled Greece, Italy, Spain, and Portugal. China’s growing rural hospital market lacks basic diagnostics laboratory infrastructure and represents an untapped opportunity for affordable immunochemistry analyzers.

Immunochemistry Analyzer Market : Key Players

The market is fully fragmented with leading brands, such as Siemens, Abbott Diagnostics, Beckman Coulter, Ortho Clinical Diagnostics, Thermo Fisher Scientific Inc.  and F. Hoffmann-La Roche Ltd.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-9189

The report covers exhaustive analysis on:

Market Segments

Market Dynamics

Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies involved

Technology

Value Chain

Regional analysis includes

North America (U.S., Canada)

Latin America (Brazil)

Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)

Eastern Europe (Poland, Russia)

Asia Pacific (China, India, ASEAN, Australia & New Zealand)

Japan

Middle East and Africa (GCC, S. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Immunochemistry Analyzer Market:Segmentation

Immunochemistry analyzer market is segmented into following types:

Instruments

Reagents

Global immunochemistry analyzer Market, by Instrument Type

Instruments

Immunochemistry Analyzers

Chemiluminescence Immunoassay (CLIA) Analyzers

Immuno Fluorescence (IFA) Analyzers

Enzyme Immunoassay (EIA) Analyzers

Radioimmunoassay (RIA) Analyzers

Enzyme Linked Fluorescent Assay (ELFA) Systems

Multiplexed Assay Systems

Immunochemistry Stainers

Automated Stainers

Semi-Automated Stainers

Global Immunochemistry analyzer Market, By Application

Endocrinology

Oncology

Cardiology

Therapeutic Drug Development & Monitoring

Infectious Disease Testing

Drugs Of Abuse Testing

Others

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-9189

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Must-have information for market players to sustain and enhance their market footprint

Cytotoxic Drugs Market size is Expected to Reach US$ 17 Billion in 2028 | Exhibit a CAGR of 0.9%

The company delivers the key insights on the global cytotoxic drugs market in its upcoming report titled “Cytotoxic Drugs Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028”. In terms of revenue, the global Cytotoxic Drugs market is projected to register a CAGR of 0.9% over the forecast period, owing to various factors, regarding which the company offers detailed insights and forecast.

The Cytotoxic Drugs market is segmented based on product type, by drug type, by route of administration, end users and regions. By drug type, the Cytotoxic Drugs market is segmented into; Alkylating Agents, Antitumor Antibiotics, Antimetabolites, Plant Alkaloids and Others. The Antimetabolites segment is expected to account a high share in the Cytotoxic Drugs market, with a growth rate of 1.2% by 2028. The Alkylating Agents segment is expected to witness a sluggish growth in the global Cytotoxic Drugs market due to market response over the use of such drug.

Cytotoxic Drugs Market: Dynamics

The growth of the Cytotoxic Drugs market is directly related to increased prevalence of cancer and higher access to the cancer care industry across the globe. Cytotoxic drugs are first line of treatment through chemotherapy in most cancer cases. As the technology continues to advance in traditional methods, it betters the further improvement in treatments and outcomes coming out of such technology.

Cytotoxic drugs are prescribed in lower doses and they function as immune suppressants.  Cytotoxic drugs can be classified as disease-modifying anti-rheumatic drugs (DMARDs). Thus application of cytotoxic drugs in treatment of rheumatic diseases provides lucrative opportunity for these cytotoxic drugs manufacturers.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-2515

However, there are numerous complications in the use in the cytotoxic drugs, which are meant to kill the entire cell or just disturb the DNA strand in order to stop the growth of cancerous cells. Most of the cytotoxic drugs are suspected to be carcinogenic, mutagenic and teratogenic in nature.

Easier availability of Cytotoxic Drugs to match the cancer care standards across the globe has led to changing clinical approach towards chemotherapy treatment. Generic cytotoxic drugs are enjoy higher demand and are well accepted in emerging markets as they are cost-effective and offer good quality. Reimbursements policies for Cytotoxic Drugs however varies from region to region. Availability of competitive alternate treatment options impact revenue growth of cytotoxic drugs market.

Cost of development of cytotoxic drugs is very high and has been increasing over past years. The main cause of cost increase is due to the various technical, regulatory and economic constraints imposed during the development process of a cytotoxic drug.

The cytotoxic drugs market is experiencing a stable growth, which happens to be because of many related causes. One of the influences being growth of outsourcing manufacturing of cytotoxic products in order to balance the cost breakdown. The parallel growth of API market supports this trend. In response, contract manufacturers and developers like CDMOs are coming up with their knowledge and efficiency in order to strengthen the development of APIs and form a relation with parent organization helps the Cytotoxic Drugs market.

Cytotoxic Drugs Market: Geographical Insights

Cytotoxic Drugs report assesses the trends that are driving the growth of each segment on the global as well as regional level, and offers potential takeaways that could prove substantially useful for the manufacturers planning to enter the market.

Geographically, the global Cytotoxic Drugs market is segmented into North America, Western Europe, Eastern Europe, Latin America, Asia Pacific excluding China & Japan, China, Japan and Middle East & Africa. This report assesses the trends driving each segment and offers analysis and insights of the Cytotoxic Drugs market in specific regions. North America is expected to account the major share in the global Cytotoxic Drugs market and is expected to grow at a CAGR of 0.8%. APECJ is expected to have the highest growth rate of 1.3% for the global Cytotoxic Drugs market during the forecast period due to the growing number of cases and production facilities for small molecules APIs.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-2515

Cytotoxic Drugs Market: Key Players

Sanofi,

Pfizer,

Novartis AG,

Johnson and Johnson,

F. Hoffmann-La Roche AG,

Lonza,

Celgene Corp.,

Amgen Inc.,

GlaxoSmithKline PLC,

Merck & Co., Inc.,

Eli Lilly and Company and Teva Pharmaceutical.

In this cytotoxic drugs market report, we have discussed the individual strategies followed by cytotoxic drug manufacturers regarding the improvements in their products, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The cytotoxic drugs report has been concluded with key takeaways for players already present in the market and new players planning to enter the Cytotoxic Drugs market.

Key Segments

The report analyses the global Cytotoxic Drugs market based on the regions and presents the forecast in terms of value for the next 10 years. The regions covered in the report include:

North America

Latin America

Western Europe

Eastern Europe

APECJ

Japan

China

Middle East & Africa

The report analyses the global Cytotoxic Drugs market based on the product type and presents the forecast in terms of value for the next 10 years. The product types covered in the report include: 

Branded Drugs

Generic Drugs

The report analyses the global Cytotoxic Drugs market based on the drug type segment and presents the forecast in terms of value for the next 10 years. The drug type covered in the report include:  

Alkylating Agents

Antitumor Antibiotics

Antimetabolites

Plant Alkaloids

Others

The report analyses the global Cytotoxic Drugs market based on the Route of Administration segment and presents the forecast in terms of value for the next 10 years. The Route of Administration covered in the report include:  

Oral

Parenteral

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-2515

The report analyses the global Cytotoxic Drugs market based on the End User segment and presents the forecast in terms of value for the next 10 years. The End User covered in the report include:  

Hospital

Cancer Research Center

Drug Testing Laboratory

CDMOs

Single Dose Radiotherapy Services Market estimated to register a CAGR of 6.1% during the forecast period of 2022 – 2030

In single-dose radiotherapy, a single dose of radiation is delivered directly to the tumor in a few minutes and is said to be a safe and effective method for treating men having low-risk prostate cancer. According to Future Market Insights (FMI), the demand for single-dose therapy is expected to rise considerably, enabling the market to surpass US$ 1.1 Bn by 2021. In the coming years the rising cases of breast cancer will support the expansion of the market.

In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for single-dose radiotherapy. The report tracks the global sales of single-dose radiotherapy in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on radiotherapy services in general, and single-dose radiotherapy services in particular.

The increasing incidence of breast cancer and prostate cancer has necessitated innovation in single-dose radiotherapy. As per the Centers for Disease Control and Prevention (CDC), prostate cancer is the second most frequently occurring type of cancer in men above the age of 45 years and breast cancer is one of the leading types of cancer among women across the globe.

Request a report sample to obtain authentic analysis and comprehensive market insights at- https://www.futuremarketinsights.com/reports/sample/rep-gb-13033

Single Dose Radiotherapy offers advantages such as high precision, greater patient comfort, cost-effectiveness, and better cosmetic outcomes in the treatment of breast cancer and prostate cancer. It is also recognized as an extremely cost-effective treatment compared with other cancer treatments. These factors are driving the adoption of single-dose radiotherapy services for breast cancer and prostate cancer.

Increasing technological advancements in radiotherapy procedure for the treatment of breast cancer and prostate cancer have led to the surging adoption of single-dose radiotherapies in clinical practice associated with improved outcomes. Single-dose radiotherapy is recognized as an extremely cost-effective treatment compared with other cancer treatments.

Increasing investments in the market, increasing number of research and development projects, and favorable regulatory policies are some factors enabling growth in the single dose radiotherapy services market. For example various government organizations such as American Cancer Society is investing in research and development programs for development of single dose radiotherapy. Recently the American cancer society have funded almost 162 research programs with around $67 million to encourage breast cancer research activities.

The COVID-19 pandemic has changed the national healthcare significances and expenditure however this is considered to be a short-term impact on the single-dose radiotherapy services market. The single-dose radiotherapy services market is expected to experience short-term negative growth owing to a sharp reduction in the number of single-dose radiotherapy services adoption rate in developed and emerging countries.

Discover more about report analysis with figures and data tables, along with the table of contents. Ask an Analyst- https://www.futuremarketinsights.com/ask-question/rep-gb-13033

As a result of the continuing spread of COVID-19, various service providers are focusing on a novel approach to the treat pneumonia associated with COVID-19 using a single low dose of external beam radiation therapy which is known as Single Dose Radiation Therapy (SDRT). Previously various studies are reported regarding use of single small fraction of radiation to treat viral and bacterial pneumonia. Thus, scientists are believing that one small dose of radiotherapy can be effective for covid-19 treatment. This is providing an opportunity for single dose radiotherapy market to grow.

Key Takeaways from Single-Dose Radiotherapy Services Market Study

  • Despite restricted growth amid COVID-19, the demand for single dose radiotherapy is expected to rise at nearly 5% in 2021
  • As a result of increasing incidence of breast cancer, the U.S. will account for over 90% sales in North America
  • Increasing focus on early diagnosis will enable the U.K. register 2.4% Y-o-Y growth in 2021
  • Germany and France are expected to exhibit increasing demand to tackle concerns pertaining to rising incidence of cancer
  • Increasing focus on research and development will drive growth in Japan and South Korea

 “Rising prevalence along with increasing awareness regarding breast and prostate cancer and the importance of early diagnosis, besides favorable reimbursement will offer lucrative growth opportunities for service providers in the long term,” says the FMI Analyst

Competitive Landscape

The global market is set to expand in the forecast period, due to the rising prevalence of breast cancer and prostate cancer globally and the adoption of single-dose radiotherapy. Leading organizations within the market are set to focus on research and development to offer early and precise diagnosis of the ailment, besides offering effective patient care.

Contact Sales for Further Assistance in Purchasing this Report- https://www.futuremarketinsights.com/checkout/13033 

Table Of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Global Market Analysis

1.3. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Market Background

3.1. Macro-Economic Factors

3.1.1. Global GDP Growth Outlook

3.1.2. Global Healthcare Expenditure Outlook

3.1.3. Growth of Healthcare Sector in Emerging Nations

3.2. Forecast Factors – Relevance & Impact

3.2.1. Global Increase in Healthcare Expenditure

3.2.2. Rising Prevalence of Breast Cancer

3.3. Market Dynamics

3.3.1. Drivers

3.3.2. Restraints

3.3.3. Opportunity Analysis

4. Market Context

4.1. Regulatory Scenario

4.2. Reimbursement Scenario

4.3. Treatment Regime

4.4. Therapy Adoption / Usage Analysis

4.5. Disease Epidemiology

4.6. Treatment Cost Analysis

5. COVID19 Crisis Impact Analysis

Smart Pill Boxes & Bottles Market is impressive rate of 10.4% CAGR, over the Forecast period 2021-2028

Sales of smart pill boxes and bottles are likely to reach around 800 thousand in 2019. According to a new analytical research study by Future Market Insights (FMI), smart pill boxes and bottles market will remain a high growth-low volume landscape over the course of next few years. Over 43% of total sales will be accounted by smart pill boxes. The report envisages a higher rate of adoption for smart pill bottles.

Almost 70% of adult patients are observed to discontinue or manipulate drug therapy, resulting in non-adherence to prescribed medication. The study opines that this directly adds to the economic burden on healthcare delivery system in form of emergency cases and hospitalization.

Smart pill boxes and bottles are increasingly being perceived as a potential solution to such challenges posed by increased healthcare delivery costs. Significance of medication adherence continues to rise with increasing prevalence of chronic conditions, propelling demand for smart pill boxes and bottles.

Dementia and geriatric care remain the key application areas of smart pill boxes and bottles, according to the report. More than 80% of sales is accounted by aging patients and dementia-afflicted population. Cancer management is likely to emerge lucrative in terms of applicability in coming years.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1710

With surging demand for high-quality healthcare delivery, senior care centers, hospitals, long-term care centers, and homecare settings are accelerating adoption of medication dispensers, thereby elevating the revenue growth of smart pill boxes and bottles market. Some of the leading companies are actively involved in the development of advanced technology medication dispensing devices with zero error risks during medication.

Home care settings maintain the highest consumption share in smart pill boxes and bottles market that roughly equates 65% of total sales. Almost a fifth of smart pill boxes and bottles sold are installed at seniors care and assisted living centers. FMI’s analysis indicates that long-term care centers are also creating promising market opportunities for smart pill boxes and bottles manufacturers and distributors.

North America continues to reign supreme owing to early adoption of advanced technology enabled smart pill boxes and bottles, accounting for more than a third of the global market revenue. European market for smart pill boxes and bottles also represents a substantial volume share, majorly driven by German patients. South and East Asian regions are briskly developing high-potential markets for manufacturers and distributors of smart pill boxes and bottles, says the report.

The vendor landscape of smart pill boxes and bottles market remains fairly consolidated and competitive, as Tier 1 manufacturers continue to account for a majority of share in the market in terms of volume. While dominance of Koninklijke Philips N.V., PharmRight Corporation & Livi, and AdhereTech prevails in smart pill boxes and bottles market, the report finds that the competition among these players is characterized by product innovation, new launches, and technological advancements.

FMI has tracked market performance for a decade-old projection period – 2018-2028. For exclusive insights on the various other aspects of smart pill boxes and bottles market landscape, write to the analyst at press@futuremarketinsights.com

key players featured in this report include

AdhereTech,

Koninklijke Philips N.V.,

MedMinder,

PharmRight Corporation & Livi,

Medipense Inc., e-pill,

LLC,

MedReady Inc.,

Pillsy, Inc.,

DoseSmart Inc,

SMRxT INC,

Pillo, Inc. and PillDrill, Inc.

Get a Customized Scope to Match Your Need Ask an Expert  @ https://www.futuremarketinsights.com/ask-question/rep-gb-1710

Key Segment

By product type

Smart Pill Box

Smart Pill Bottles

By indication

dementia

Parkinson’s disease

cancer management

diabetes care

geriatric care

disability

others

By end user

Seniors Care & Assisted Living

Long Term Care Centers

Home Care Settings

By regions

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East & Africa (MEA)

Additional Questions Answered

Some of the additional questions addressed in this report on the Smart Pill Boxes & Bottles market:

What is the overall revenue generation potential of the Smart Pill Boxes & Bottles market across the regions of Europe and South Asia?

Who are the key regional and global competitors? What are their portfolios in the Smart Pill Boxes & Bottles market?

What are the major challenges influencing the growth of the Smart Pill Boxes & Bottles market?